192 related articles for article (PubMed ID: 22247247)
1. Intestinal failure-associated liver disease in hospitalised children.
Pichler J; Horn V; Macdonald S; Hill S
Arch Dis Child; 2012 Mar; 97(3):211-4. PubMed ID: 22247247
[TBL] [Abstract][Full Text] [Related]
2. Parenteral plant sterols and intestinal failure-associated liver disease in neonates.
Kurvinen A; Nissinen MJ; Andersson S; Korhonen P; Ruuska T; Taimisto M; Kalliomäki M; Lehtonen L; Sankilampi U; Arikoski P; Saarela T; Miettinen TA; Gylling H; Pakarinen MP
J Pediatr Gastroenterol Nutr; 2012 Jun; 54(6):803-11. PubMed ID: 22197940
[TBL] [Abstract][Full Text] [Related]
3. The prevention and treatment of intestinal failure-associated liver disease in neonates and children.
Nehra D; Fallon EM; Puder M
Surg Clin North Am; 2011 Jun; 91(3):543-63. PubMed ID: 21621695
[TBL] [Abstract][Full Text] [Related]
4. Reversal of intestinal failure-associated liver disease in infants and children on parenteral nutrition: experience with 93 patients at a referral center for intestinal rehabilitation.
Cowles RA; Ventura KA; Martinez M; Lobritto SJ; Harren PA; Brodlie S; Carroll J; Jan DM
J Pediatr Surg; 2010 Jan; 45(1):84-7; discussion 87-8. PubMed ID: 20105585
[TBL] [Abstract][Full Text] [Related]
5. Intestinal failure-associated liver disease: what do we know today?
Kelly DA
Gastroenterology; 2006 Feb; 130(2 Suppl 1):S70-7. PubMed ID: 16473076
[TBL] [Abstract][Full Text] [Related]
6. Intestinal failure-associated liver disease in surgical infants requiring long-term parenteral nutrition.
Bishay M; Pichler J; Horn V; Macdonald S; Ellmer M; Eaton S; Hill S; Pierro A
J Pediatr Surg; 2012 Feb; 47(2):359-62. PubMed ID: 22325390
[TBL] [Abstract][Full Text] [Related]
7. Incidence, prevention, and treatment of parenteral nutrition-associated cholestasis and intestinal failure-associated liver disease in infants and children: a systematic review.
Lauriti G; Zani A; Aufieri R; Cananzi M; Chiesa PL; Eaton S; Pierro A
JPEN J Parenter Enteral Nutr; 2014 Jan; 38(1):70-85. PubMed ID: 23894170
[TBL] [Abstract][Full Text] [Related]
8. Approximately 50% of acute intestinal failure (AIF) patients on short-term parenteral nutrition (PN) have intestinal failure-associated liver disease (IFALD) without effect on hospital length of stay and mortality.
Cheang LY; Chong NCJ; Poh BY; Tan LB; Goh JLR; Lee MS; Tan KCT; Kadir HA; Cheah CCM; Salazar E
Clin Nutr ESPEN; 2024 Jun; 61():140-144. PubMed ID: 38777425
[TBL] [Abstract][Full Text] [Related]
9. Intestinal failure-associated liver disease (IFALD): insights into pathogenesis and advances in management.
Lee WS; Chew KS; Ng RT; Kasmi KE; Sokol RJ
Hepatol Int; 2020 May; 14(3):305-316. PubMed ID: 32356227
[TBL] [Abstract][Full Text] [Related]
10. Prediction, identification and progression of histopathological liver disease activity in children with intestinal failure.
Mutanen A; Lohi J; Merras-Salmio L; Koivusalo A; Pakarinen MP
J Hepatol; 2021 Mar; 74(3):593-602. PubMed ID: 33002568
[TBL] [Abstract][Full Text] [Related]
11. Recent advances in the management of intestinal failure-associated liver disease.
Wiles A; Woodward JM
Curr Opin Clin Nutr Metab Care; 2009 May; 12(3):265-72. PubMed ID: 19339882
[TBL] [Abstract][Full Text] [Related]
12. Improved outcome in neonatal short bowel syndrome using parenteral fish oil in combination with ω-6/9 lipid emulsions.
Angsten G; Finkel Y; Lucas S; Kassa AM; Paulsson M; Lilja HE
JPEN J Parenter Enteral Nutr; 2012 Sep; 36(5):587-95. PubMed ID: 22275330
[TBL] [Abstract][Full Text] [Related]
13. Prevention and Treatment of Intestinal Failure-Associated Liver Disease in Children.
Norsa L; Nicastro E; Di Giorgio A; Lacaille F; D'Antiga L
Nutrients; 2018 May; 10(6):. PubMed ID: 29882922
[TBL] [Abstract][Full Text] [Related]
14. Novel lipid-based approaches to pediatric intestinal failure-associated liver disease.
Diamond IR; Pencharz PB; Feldman BM; Ling SC; Moore AM; Wales PW
Arch Pediatr Adolesc Med; 2012 May; 166(5):473-8. PubMed ID: 22566549
[TBL] [Abstract][Full Text] [Related]
15. Intestinal failure-associated liver disease: management and treatment strategies past, present, and future.
Carter BA; Karpen SJ
Semin Liver Dis; 2007 Aug; 27(3):251-8. PubMed ID: 17682972
[TBL] [Abstract][Full Text] [Related]
16. [Liver complications associated with short-term parenteral nutrition in children].
Moreno Villares JM; Gomis Muñoz P; Galiano Segovia MJ; Valero Zanuy MA; Serrano Garrote O; León Sanz M
An Esp Pediatr; 1999 Jul; 51(1):22-6. PubMed ID: 10452141
[TBL] [Abstract][Full Text] [Related]
17. Innovative parenteral and enteral nutrition therapy for intestinal failure.
Le HD; Fallon EM; de Meijer VE; Malkan AD; Puder M; Gura KM
Semin Pediatr Surg; 2010 Feb; 19(1):27-34. PubMed ID: 20123271
[TBL] [Abstract][Full Text] [Related]
18. New Insights Into Intestinal Failure-Associated Liver Disease in Children.
Khalaf RT; Sokol RJ
Hepatology; 2020 Apr; 71(4):1486-1498. PubMed ID: 32003009
[TBL] [Abstract][Full Text] [Related]
19. Clinical outcome in patients from a single region who were dependent on parenteral nutrition for 28 days or more.
Köglmeier J; Day C; Puntis JW
Arch Dis Child; 2008 Apr; 93(4):300-2. PubMed ID: 18192319
[TBL] [Abstract][Full Text] [Related]
20. Liver function test alterations associated with parenteral nutrition in hospitalized adult patients: incidence and risk factors.
Badia-Tahull MB; Leiva-Badosa E; Llop-Talaverón J; Figueras-Suriol A; Quirante-Cremades A; Tubau-Molas M; Jódar-Masanés R
Nutr Hosp; 2012; 27(4):1279-85. PubMed ID: 23165574
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
